A20 haploinsufficiency (HA20): Clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease

Florence A. Aeschlimann, Ezgi D. Batu, Scott W. Canna, Ellen Go, Ahmet Gül, Patrycja Hoffmann, Helen L. Leavis, Seza Ozen, Daniella M. Schwartz, Deborah L. Stone, Annet Van Royen-Kerkhof, Daniel L. Kastner, Ivona Aksentijevich, Ronald M. Laxer*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A20 haploinsufficiency (HA20): Clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Immunology and Microbiology